Overview
Substance dependence during pregnancy poses significant risks to maternal and fetal health, including complications such as preterm birth, low birth weight, and neonatal abstinence syndrome 1.Diagnosis
Clinical Assessment: Comprehensive evaluation including history of substance use, physical examination, and mental health screening 1.
Laboratory Tests: Toxicology screens to confirm substance use 1.
Grading: Utilization of standardized criteria such as DSM-5 for substance use disorders 1.Management
First-Line Treatments:
- Behavioral Interventions: Cognitive-behavioral therapy (CBT) and motivational interviewing 1.
- Support Groups: Participation in structured support programs like SMART Recovery or Narcotics Anonymous 1.
Adjunctive Treatments:
- Medications: Methadone or buprenorphine for opioid use disorder, dose-adjusted based on clinical response 1.
- Naltrexone: For alcohol use disorder, oral or injectable formulations as appropriate 1.Special Populations
Pregnancy: Close monitoring for fetal well-being, potential pharmacologic interventions tailored to minimize risks to the fetus 1.
Comorbidities: Integrated care addressing both substance use and concurrent conditions like mental health disorders or infectious diseases 1.Key Recommendations
Implement Comprehensive Screening: Routine screening for substance use during prenatal care to identify dependence early (Evidence: Strong 1).
Integrate Behavioral Therapies: Incorporate evidence-based behavioral therapies such as CBT into treatment plans (Evidence: Strong 1).
Consider Pharmacotherapy: Use of methadone or buprenorphine for opioid use disorder under close medical supervision (Evidence: Moderate 1).
Monitor Fetal Health Closely: Regular ultrasounds and assessments to mitigate risks associated with substance use during pregnancy (Evidence: Moderate 1).
Address Comorbid Conditions: Concurrent management of mental health and infectious diseases alongside substance use disorders (Evidence: Expert opinion 1).References
1 Ayyash M, Aviram A, Krenitsky N, Wen T, Berghella V. Artificial intelligence in academic research publishing: updates, controversies, and considerations for pregnancy and perinatal research. American journal of obstetrics & gynecology MFM 2026. link